erlotinib,osimertinib,bevacizumab
astrazeneca,roche
[' erlo', 'bevacizumab', 'osimertinib', 'nsclc', 'sclc']
 in elegant presentation about resistance mechanisms in #nsclc post osimertinib #esmo22 in my practice i have see some case with longer survival when i began erlotinib #bevacizumab and change to #osimertinib in progression. real world cases can help! 
Medical Oncology at https://t.co/hCfxKt8kbP and https://t.co/YeizvuTGR3 Opinions are my own.